Cyclodextrin nanosponges as bioenhancers of phytochemicals

Bartłomiej Pyrak; Tomasz Gubica; Karolina Rogacka-Pyrak

doi:10.56782/pps.272

Published : 2024-09-23

Vol. 22 No. 3 (2024)

Cyclodextrin nanosponges as bioenhancers of phytochemicals

Bartłomiej Pyrak

Tomasz Gubica

Karolina Rogacka-Pyrak

DOI: https://doi.org/10.56782/pps.272

Abstract

Bioavailability is the biggest obstacle to the effectiveness of biologically active compounds. Based on a set of physicochemical requirements we can determine if the compound fulfills the drug-like character and if it has the potential to become an active pharmaceutical ingredient (API) with confirmed and thoroughly examined activities. This practice is widely used in drug design of entirely new APIs, but also in search of pharmacological active substances in large compound bases such as plant-derived substances. The chemical structure diversity of plant-based compounds assures that some of them have to be well bioavailable due to good lipid membrane permeability. However, their efficiency is often limited by poor water solubility. Thus, there is a special need for bioenhancers of naturally derived compounds. In this review we present the potential of cyclodextrin nanosponges (CDNSs) as bioavailability enhancers of selected phytochemicals, namely curcumin, resveratrol, oxyresveratrol and quercetin whose very poor water solubility is the biggest obstacle to high efficiency.

Keywords:

cyclodextrin nanosponge, phytochemicals, bioavailability, bioenhancers

Similar Articles

Łukasz Szeleszczuk, Marzena Kuras, THE ROLE OF CALCIUM IN HUMAN METABOLISM AND FACTORS AFFECTING ITS BIOAVAILABILITY , Prospects in Pharmaceutical Sciences: Vol. 12 No. 3 (2014)
Magdalena Bamburowicz-Klimkowska, Urszula Bogucka, Mirosław M. Szutowski, FUNCTIONS OF ATP-BINDING CASSETTE (ABC) TRANSPORTERS , Prospects in Pharmaceutical Sciences: Vol. 9 No. 3 (2011)
Aleksandra Kowalska, The Vitamin E: overview of history of discovery, mechanism of action, role and deficiency , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Ramona Figat, PHENOLIC ACIDS – ANTIGENOTOXIC COMPOUNDS FROM MEDICINAL AND EDIBLE PLANTS , Prospects in Pharmaceutical Sciences: Vol. 19 No. 4 (2021)
Agnieszka Sokal, Edyta Pindelska, COCRYSTALS - A NEW DRUG FORM , Prospects in Pharmaceutical Sciences: Vol. 11 No. 5 (2013)
Elżbieta Gniazdowska, Edyta Gilant, Katarzyna Buś-Kwaśnik, ICH M10 guideline - a harmonized global approach to bioanalysis , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Ewa Napiórkowska, Overview of cyclodextrins and medicinal products containing cyclodextrins currently registered in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Diana Dolzhko, Natalia Melnyk, Aleksandra Kruk, Sebastian Granica, Jakub Piwowarski, Traditional use of polar extracts from lavender flowers – systematic review of literature data , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Pyrak, B., Gubica, T., & Rogacka-Pyrak, K. (2024). Cyclodextrin nanosponges as bioenhancers of phytochemicals. Prospects in Pharmaceutical Sciences, 22(3), 170–177. https://doi.org/10.56782/pps.272

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 1997, 23, 3-25. doi:10.1016/s0169-409x(96)00423-1.

Veber, D.F.; Johnson, S.R.; Cheng, H.-Y.; Smith, B.R.; Ward, K.W.; Kopple, K.D. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002, 45, 2615-2623. doi:10.1021/jm020017n.

Amidon, G.L.; Lennernas, H.; Shah, V.P.; Crison, J.R. A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 1995, 12, 413-420. doi:10.1023/a:1016212804288.

Rajput, K.N.; Patel, K.C.; Trivedi, U.B. β-Cyclodextrin Production by Cyclodextrin Glucanotransferase from an Alkaliphile Microbacterium terrae KNR 9 Using Different Starch Substrates. Biotechnol. Res. Int. 2016, 2016, Art. No: 2034359. doi:10.1155/2016/2034359.

Vyas, A.; Saraf, S.; Saraf, S. Cyclodextrin based novel drug delivery systems. J. Incl. Phenom. Macrocycl. Chem. 2008, 62, 23-42. doi:10.1007/s10847-008-9456-y.

Chilajwar, S.V.; Pednekar, P.P.; Jadhav, K.R.; Gupta, G.J.C.; Kadam, V.J. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery. Expert Opin. Drug. Deliv. 2014, 11, 111-120. doi:10.1517/17425247.2014.865013.

Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol. 2010, 62, 1607-1621. doi:10.1111/j.2042-7158.2010.01030.x.

Pawar, S.; Shende, P.; Trotta, F. Diversity of beta-cyclodextrin-based nanosponges for transformation of actives. Int. J. Pharm. 2019, 565, 333-350. doi:10.1016/j.ijpharm.2019.05.015.

Jambhekar, S.S.; Breen, P. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discov. Today 2016, 21, 356-362. doi:10.1016/j.drudis.2015.11.017.

Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85, 1017-1025. doi:10.1021/js950534b.

Li, D.; Ma, M. Nanoporous polymers: New nanosponge absorbent media. Filtr. Sep. 1999, 36, 26-28. doi:10.1016/S0015-1882(00)80050-6.

Ma, M.; Li, D.Q. New organic nanoporous polymers and their inclusion complexes. Chem. Mater. 1999, 11, 872-874. doi:10.1021/cm981090y.

Trotta, F.; Zanetti, M.; Cavalli, R. Cyclodextrin-based nanosponges as drug carriers. Beilstein J. Org. Chem. 2012, 8, 2091-2099. doi:10.3762/bjoc.8.235.

Brewster, M.E.; Loftsson, T. Cyclodextrins as pharmaccutical solubilizers. Adv. Drug Del. Rev. 2007, 59, 645-666. doi:10.1016/j.addr.2007.05.012.

Loftsson, T.; Jarho, P.; Másson, M.; Järvinen, T. Cyclodextrins in drug delivery. Expert Opin. Drug. Deliv. 2005, 2, 335-351. doi:10.1517/17425247.2.1.335.

Pyrak, B.; Rogacka-Pyrak, K.; Gubica, T.; Szeleszczuk, L. Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics. Int. J. Mol. Sci. 2024, 25(6), Art. No: 3527. doi:10.3390/ijms25063527.

Shoaib, Q.U.A.; Latif, S.; Ijaz, Q.A.; Afzal, H.; Siddique, M.I.; Hussain, A.; Arshad, M.S.; Bukhari, N.I.; Abbas, N. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges. Pak. J. Pharm. Sci. 2021, 34, 1045-1055. doi:10.36721/pjps.2021.34.3.sup.1045-1055.1.

Gaber, D.A.; Radwan, M.A.; Alzughaibi, D.A.; Alail, J.A.; Aljumah, R.S.; Aloqla, R.M.; Alkhalifah, S.A.; Abdoun, S.A. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity. Drug Deliv. 2023, 30(1), Art. No: 2174208. doi:10.1080/10717544.2023.2174208.

Mendes, C.; Meirelles, G.C.; Barp, C.G.; Assreuy, J.; Silva, M.A.S.; Ponchel, G. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity. Carbohydr. Polym. 2018, 195, 586-592. doi:10.1016/j.carbpol.2018.05.011.

Rao, M.R.P.; Chaudhari, J.; Trotta, F.; Caldera, F. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine. AAPS PharmSciTech 2018, 19, 2358-2369. doi:10.1208/s12249-018-1064-6.

Mashaqbeh, H.; Obaidat, R.; Al-Shar'i, N.; El-Elimat, T.; Alnabulsi, S. Weak complexation of 5-fluorouracil with beta-cyclodextrin, carbonate, and dianhydride crosslinked beta-cyclodextrin: in vitro and in silico studies. Res. Pharm. Sci. 2022, 17, 334-349. doi:10.4103/1735-5362.350235.

Argenziano, M.; Gigliotti, C.L.; Clemente, N.; Boggio, E.; Ferrara, B.; Trotta, F.; Pizzimenti, S.; Barrera, G.; Boldorini, R.; Bessone, F.; et al. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models. Cancers 2020, 12, Art. No: 162. doi:10.3390/cancers12010162.

Suvarna, V.; Singh, V.; Sharma, D.; Murahari, M. Experimental and computational insight of the supramolecular complexes of Irbesartan with beta-cyclodextrin based nanosponges. J. Drug Deliv. Sci. Technol. 2021, 63, Art. No: 102494. doi:10.1016/j.jddst.2021.102494.

Vij, M.; Dand, N.; Kumar, L.; Wadhwa, P.; Wani, S.U.D.; Mahdi, W.A.; Alshehri, S.; Alam, P.; Shakeel, F. Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug. Pharmaceuticals 2023, 16, Art. No: 567. doi:10.3390/ph16040567.

Sherje, A.P.; Surve, A.; Shende, P. CDI cross-linked -cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization. J. Mater. Sci. Mater. Med. 2019, 30, Art. No: 74. doi:10.1007/s10856-019-6268-0.

Bertelli, A.; Biagi, M.; Corsini, M.; Baini, G.; Cappellucci, G.; Miraldi, E. Polyphenols: From Theory to Practice. Foods 2021, 10(11), Art. No: 2595. doi:10.3390/foods10112595.

Panahi, Y.; Fazlolahzadeh, O.; Atkin, S.L.; Majeed, M.; Butler, A.E.; Johnston, T.P.; Sahebkar, A. Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. J. Cell. Physiol. 2019, 234, 1165-1178. doi:10.1002/jcp.27096.

Qureshi, S.; Shah, A.H.; Ageel, A.M. Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med. 1992, 58, 124-127. doi:10.1055/s-2006-961412.

Lao, C.D.; Demierre, M.F.; Sondak, V.K. Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Rev. Anticancer Ther. 2006, 6, 1559-1568. doi:10.1586/14737140.6.11.1559.

Chelimela, N.; Alavala, R.; Satla, S. Curcumin - Bioavailability Enhancement by Prodrug Approach and Novel Formulations. Chem. Biodivers. 2024, 21(5), Art. No: e202302030. doi:10.1002/cbdv.202302030.

Siviero, A.; Gallo, E.; Maggini, V.; Gori, L.; Mugelli, A.; Firenzuoli, F.; Vannacci, A. Curcumin, a golden spice with a low bioavailability. J. Herb. Med. 2015, 5, 57-70. doi:10.1016/j.hermed.2015.03.001.

Pushpalatha, R.; Selvamuthukumar, S.; Kilimozhi, D. Cross-linked, cyclodextrin-based nanosponges for curcumin delivery - Physicochemical characterization, drug release, stability and cytotoxicity. J. Drug Deliv. Sci. Technol. 2018, 45, 45-53. doi:10.1016/j.jddst.2018.03.004.

Kharat, M.; Du, Z.; Zhang, G.; McClements, D.J. Physical and Chemical Stability of Curcumin in Aqueous Solutions and Emulsions: Impact of pH, Temperature, and Molecular Environment. J. Agric. Food. Chem. 2017, 65, 1525-1532. doi:10.1021/acs.jafc.6b04815.

Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4, 807-818. doi:10.1021/mp700113r.

Wu, C.-F.; Yang, J.-Y.; Wang, F.; Wang, X.-X. Resveratrol: botanical origin, pharmacological activity and applications. Chinese Journal of Natural Medicines 2013, 11, 1-15. doi:10.1016/S1875-5364(13)60001-1.

Amri, A.; Chaumeil, J.C.; Sfar, S.; Charrueau, C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J. Control. Release 2012, 158, 182-193. doi:10.1016/j.jconrel.2011.09.083.

NCBI. PubChem Compound Summary for CID 445154, Resveratrol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Resveratrol (accessed on September 7, 2024).

Dhakar, N.K.; Matencio, A.; Caldera, F.; Argenziano, M.; Cavalli, R.; Dianzani, C.; Zanetti, M.; Lopez-Nicolas, J.M.; Trotta, F. Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges. Pharmaceutics 2019, 11, Art. No: 545. doi:10.3390/pharmaceutics11100545.

Jagtap, S.; Meganathan, K.; Wagh, V.; Winkler, J.; Hescheler, J.; Sachinidis, A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr. Med. Chem. 2009, 16, 1451-1462. doi:10.2174/092986709787909578.

Li, H.; Zhao, X.; Ma, Y.; Zhai, G.; Li, L.; Lou, H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 2009, 133, 238-244. doi:10.1016/j.jconrel.2008.10.002.

Ross, J.A.; Kasum, C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22, 19-34. doi:10.1146/annurev.nutr.22.111401.144957.

NCBI. PubChem Compound Summary for CID 5280343, Quercetin. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Quercetin (accessed on September 7, 2024).

Singireddy, A.; Subramanian, S. Cyclodextrin nanosponges to enhance the dissolution profile of quercetin by inclusion complex formation. Particul. Sci. Technol. 2016, 34, 341-346. doi:10.1080/02726351.2015.1081658.

NCBI. PubChem Compound Summary for CID 969516, Curcumin. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Curcumin (accessed on September 7, 2024).

NCBI. PubChem Compound Summary for CID 5281717, Oxyresveratrol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Oxyresveratrol (accessed on September 7, 2024).

Cheng, T.; Zhao, Y.; Li, X.; Lin, F.; Xu, Y.; Zhang, X.; Li, Y.; Wang, R.; Lai, L. Computation of Octanol−Water Partition Coefficients by Guiding an Additive Model with Knowledge. J. Chem. Inf. Model. 2007, 47, 2140-2148. doi:10.1021/ci700257y.

Darandale, S.S.; Vavia, P.R. Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization. J. Incl. Phenom. Macrocycl. Chem. 2013, 75, 315-322. doi:10.1007/s10847-012-0186-9.

Gholibegloo, E.; Mortezazadeh, T.; Salehian, F.; Ramazani, A.; Amanlou, M.; Khoobi, M. Improved curcumin loading, release, solubility and toxicity by tuning the molar ratio of cross-linker to beta-cyclodextrin. Carbohydr. Polym. 2019, 213, 70-78. doi:10.1016/j.carbpol.2019.02.075.

Ansari, K.A.; Vavia, P.R.; Trotta, F.; Cavalli, R. Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study. AAPS PharmSciTech 2011, 12, 279-286. doi:10.1208/s12249-011-9584-3.

Mashaqbeh, H.; Obaidat, R.; Al-Shar'i, N. Evaluation and Characterization of Curcumin-beta-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation. Polymers 2021, 13, Art. No: 4073. doi:10.3390/polym13234073.

Pushpalatha, R.; Selvamuthukumar, S.; Kilimozhi, D. Carbonyl and carboxylate crosslinked cyclodextrin as a nanocarrier for resveratrol: in silico, in vitro and in vivo evaluation. J. Incl. Phenom. Macrocycl. Chem. 2018, 92, 261-272. doi:10.1007/s10847-018-0843-8.

Anandam, S.; Selvamuthukumar, S. Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. J. Mater. Sci. 2014, 49, 8140-8153. doi:10.1007/s10853-014-8523-6.

Mashaqbeh, H.; Obaidat, R.; Al-shar'i, N.A. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin. AAPS PharmSciTech 2022, 23, Art. No: 229. doi:10.1208/s12249-022-02372-z.

Rafati, N.; Zarrabi, A.; Caldera, F.; Trotta, F.; Ghias, N. Pyromellitic dianhydride crosslinked cyclodextrin nanosponges for curcumin controlled release; formulation, physicochemical characterization and cytotoxicity investigations. J. Microencapsul. 2019, 36, 715-727. doi:10.1080/02652048.2019.1669728.

Pushpalatha, R.; Selvamuthukumar, S.; Kilimozhi, D. Cyclodextrin nanosponge based hydrogel for the transdermal co-delivery of curcumin and resveratrol: Development, optimization, in vitro and ex vivo evaluation. J. Drug Deliv. Sci. Technol. 2019, 52, 55-64. doi:10.1016/j.jddst.2019.04.025.

Matencio, A.; Dhakar, N.K.; Bessone, F.; Musso, G.; Cavalli, R.; Dianzani, C.; Garcia-Carmona, F.; Lopez-Nicolas, J.M.; Trotta, F. Study of oxyresveratrol complexes with insoluble cyclodextrin based nanosponges: Developing a novel way to obtain their complexation constants and application in an anticancer study. Carbohydr. Polym. 2020, 231, Art. No: 115763. doi:10.1016/j.carbpol.2019.115763.

Gharakhloo, M.; Sadjadi, S.; Rezaeetabar, M.; Askari, F.; Rahimi, A. Cyclodextrin‐Based Nanosponges for Improving Solubility and Sustainable Release of Curcumin. ChemistrySelect 2020, 5, 1734-1738. doi:10.1002/slct.201904007.

Cyclodextrin nanosponges as bioenhancers of phytochemicals

Bartłomiej Pyrak

Tomasz Gubica

Karolina Rogacka-Pyrak

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Bartłomiej Pyrak

Tomasz Gubica

Karolina Rogacka-Pyrak